Literature DB >> 30398601

Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life.

Yuichiro Yano1, Jared P Reis2, Laura A Colangelo3, Daichi Shimbo4, Anthony J Viera1, Norrina B Allen3, Samuel S Gidding5, Adam P Bress6, Philip Greenland3, Paul Muntner7, Donald M Lloyd-Jones3.   

Abstract

Importance: Little is known regarding the association between level of blood pressure (BP) in young adulthood and cardiovascular disease (CVD) events by middle age. Objective: To assess whether young adults who developed hypertension, defined by the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) BP guideline, before age 40 years have higher risk for CVD events compared with those who maintained normal BP. Design, Setting, and Participants: Analyses were conducted in the prospective cohort Coronary Artery Risk Development in Young Adults (CARDIA) study, started in March 1985. CARDIA enrolled 5115 African American and white participants aged 18 to 30 years from 4 US field centers (Birmingham, Alabama; Chicago, Illinois; Minneapolis, Minnesota; and Oakland, California). Outcomes were available through August 2015. Exposures: Using the highest BP measured from the first examination to the examination closest to, but not after, age 40 years, each participant was categorized as having normal BP (untreated systolic BP [SBP] <120 mm Hg and diastolic BP [DBP] <80 mm Hg; n = 2574); elevated BP (untreated SBP 120-129 mm Hg and DBP <80 mm Hg; n = 445); stage 1 hypertension (untreated SBP 130-139 mm Hg or DBP 80-89 mm Hg; n = 1194); or stage 2 hypertension (SBP ≥140 mm Hg, DBP ≥90 mm Hg, or taking antihypertensive medication; n = 638). Main Outcomes and Measures: CVD events: fatal and nonfatal coronary heart disease (CHD), heart failure, stroke, transient ischemic attack, or intervention for peripheral artery disease (PAD).
Results: The final cohort included 4851 adults (mean age when follow-up for outcomes began, 35.7 years [SD, 3.6]; 2657 women [55%]; 2441 African American [50%]; 206 taking antihypertensive medication [4%]). Over a median follow-up of 18.8 years, 228 incident CVD events occurred (CHD, 109; stroke, 63; heart failure, 48; PAD, 8). CVD incidence rates for normal BP, elevated BP, stage 1 hypertension, and stage 2 hypertension were 1.37 (95% CI, 1.07-1.75), 2.74 (95% CI, 1.78-4.20), 3.15 (95% CI, 2.47-4.02), and 8.04 (95% CI, 6.45-10.03) per 1000 person-years, respectively. After multivariable adjustment, hazard ratios for CVD events for elevated BP, stage 1 hypertension, and stage 2 hypertension vs normal BP were 1.67 (95% CI, 1.01-2.77), 1.75 (95% CI, 1.22-2.53), and 3.49 (95% CI, 2.42-5.05), respectively. Conclusions and Relevance: Among young adults, those with elevated blood pressure, stage 1 hypertension, and stage 2 hypertension before age 40 years, as defined by the blood pressure classification in the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guidelines, had significantly higher risk for subsequent cardiovascular disease events compared with those with normal blood pressure before age 40 years. The ACC/AHA blood pressure classification system may help identify young adults at higher risk for cardiovascular disease events.

Entities:  

Mesh:

Year:  2018        PMID: 30398601      PMCID: PMC6248102          DOI: 10.1001/jama.2018.13551

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  27 in total

1.  Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute.

Authors:  Russell V Luepker; Fred S Apple; Robert H Christenson; Richard S Crow; Stephen P Fortmann; David Goff; Robert J Goldberg; Mary M Hand; Allan S Jaffe; Desmond G Julian; Daniel Levy; Teri Manolio; Shanthi Mendis; George Mensah; Andrzej Pajak; Ronald J Prineas; K Srinath Reddy; Veronique L Roger; Wayne D Rosamond; Eyal Shahar; A Richey Sharrett; Paul Sorlie; Hugh Tunstall-Pedoe
Journal:  Circulation       Date:  2003-11-10       Impact factor: 29.690

2.  Racial Differences in Associations of Blood Pressure Components in Young Adulthood With Incident Cardiovascular Disease by Middle Age: Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Yuichiro Yano; Jared P Reis; Yacob G Tedla; David C Goff; David R Jacobs; Stephen Sidney; Hongyan Ning; Kiang Liu; Philip Greenland; Donald M Lloyd-Jones
Journal:  JAMA Cardiol       Date:  2017-04-01       Impact factor: 14.676

Review 3.  Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.

Authors:  Donald M Lloyd-Jones; Yuling Hong; Darwin Labarthe; Dariush Mozaffarian; Lawrence J Appel; Linda Van Horn; Kurt Greenlund; Stephen Daniels; Graham Nichol; Gordon F Tomaselli; Donna K Arnett; Gregg C Fonarow; P Michael Ho; Michael S Lauer; Frederick A Masoudi; Rose Marie Robertson; Véronique Roger; Lee H Schwamm; Paul Sorlie; Clyde W Yancy; Wayne D Rosamond
Journal:  Circulation       Date:  2010-01-20       Impact factor: 29.690

4.  Isolated systolic hypertension in young and middle-aged adults and 31-year risk for cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study.

Authors:  Yuichiro Yano; Jeremiah Stamler; Daniel B Garside; Martha L Daviglus; Stanley S Franklin; Mercedes R Carnethon; Kiang Liu; Philip Greenland; Donald M Lloyd-Jones
Journal:  J Am Coll Cardiol       Date:  2015-02-03       Impact factor: 24.094

Review 5.  Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.

Authors:  A Rozanski; J A Blumenthal; J Kaplan
Journal:  Circulation       Date:  1999-04-27       Impact factor: 29.690

6.  Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT).

Authors:  Michael Domanski; Gary Mitchell; Marc Pfeffer; James D Neaton; James Norman; Kenneth Svendsen; Richard Grimm; Jerome Cohen; Jeremiah Stamler
Journal:  JAMA       Date:  2002 May 22-29       Impact factor: 56.272

7.  Evaluating the Framingham hypertension risk prediction model in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  April P Carson; Cora E Lewis; David R Jacobs; Carmen A Peralta; Lyn M Steffen; Julie K Bower; Sharina D Person; Paul Muntner
Journal:  Hypertension       Date:  2013-09-16       Impact factor: 10.190

Review 8.  Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.

Authors:  Marie Therese Cooney; Alexandra L Dudina; Ian M Graham
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

9.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  71 in total

1.  Cost-Effectiveness of Drug Treatment for Chinese Patients With Stage I Hypertension According to the 2017 Hypertension Clinical Practice Guidelines.

Authors:  Yan-Feng Zhou; Na Liu; Pei Wang; Jae Jeong Yang; Xing-Yue Song; Xiong-Fei Pan; Xiaomin Zhang; Meian He; Honglan Li; Yu-Tang Gao; Yong-Bing Xiang; Tangchun Wu; Danxia Yu; An Pan
Journal:  Hypertension       Date:  2020-07-27       Impact factor: 10.190

2.  2017 ACC/AHA blood pressure classification and incident peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Yifei Lu; Shoshana H Ballew; Hirofumi Tanaka; Moyses Szklo; Gerardo Heiss; Josef Coresh; Kunihiro Matsushita
Journal:  Eur J Prev Cardiol       Date:  2019-07-30       Impact factor: 7.804

3.  Stage 1 hypertension, but not elevated blood pressure, predicts 10-year fatal and non-fatal CVD events in healthy adults: the ATTICA Study.

Authors:  Elena Critselis; Christina Chrysohoou; Natasa Kollia; Ekavi N Georgousopoulou; Dimitrios Tousoulis; Christos Pitsavos; Demosthenes B Panagiotakos
Journal:  J Hum Hypertens       Date:  2019-02-11       Impact factor: 3.012

Review 4.  Prevalence of high blood pressure under 2017 ACC/AHA guidelines: a systematic review and meta-analysis.

Authors:  Peisheng Xiong; Zhixi Liu; Meijuan Xiong; Feng Xie
Journal:  J Hum Hypertens       Date:  2020-12-08       Impact factor: 3.012

5.  Temporal Changes in Resting Heart Rate, Left Ventricular Dysfunction, Heart Failure and Cardiovascular Disease: CARDIA Study.

Authors:  Chike C Nwabuo; Duke Appiah; Henrique T Moreira; Henrique D Vasconcellos; Queen N Aghaji; Bharath Ambale-Venkatesh; Jamal S Rana; Norrina B Allen; Donald M Lloyd-Jones; Pamela J Schreiner; Samuel S Gidding; João A C Lima
Journal:  Am J Med       Date:  2020-01-27       Impact factor: 4.965

Review 6.  Evidence for the Universal Blood Pressure Goal of <130/80 mm Hg Is Strong: Controversies in Hypertension - Pro Side of the Argument.

Authors:  Robert M Carey; Paul K Whelton
Journal:  Hypertension       Date:  2020-09-21       Impact factor: 10.190

7.  Relationship between food insecurity and high blood pressure in a national sample of children and adolescents.

Authors:  Andrew M South; Deepak Palakshappa; Callie L Brown
Journal:  Pediatr Nephrol       Date:  2019-04-26       Impact factor: 3.714

8.  Hypertension in Adults With Intellectual Disability: Prevalence and Risk Factors.

Authors:  Elizabeth C Schroeder; Lindsay DuBois; Molly Sadowsky; Thessa I M Hilgenkamp
Journal:  Am J Prev Med       Date:  2020-02-12       Impact factor: 5.043

9.  Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality.

Authors:  Victor W Zhong; Linda Van Horn; Marilyn C Cornelis; John T Wilkins; Hongyan Ning; Mercedes R Carnethon; Philip Greenland; Robert J Mentz; Katherine L Tucker; Lihui Zhao; Arnita F Norwood; Donald M Lloyd-Jones; Norrina B Allen
Journal:  JAMA       Date:  2019-03-19       Impact factor: 56.272

10.  Epigenetic Modifications in T Cells: The Role of DNA Methylation in Salt-Sensitive Hypertension.

Authors:  John Henry Dasinger; Ammar J Alsheikh; Justine M Abais-Battad; Xiaoqing Pan; Daniel J Fehrenbach; Hayley Lund; Michelle L Roberts; Allen W Cowley; Srividya Kidambi; Theodore A Kotchen; Pengyuan Liu; Mingyu Liang; David L Mattson
Journal:  Hypertension       Date:  2019-12-16       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.